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Summary A registry of haematopoietic malignancies was established on January 1, 1980 in order to
accurately determine the incidence and epidemiological features of these diseases in the department of C6te
d'Or (population 478,000). Over five years (1980-1984), 704 new cases were recorded. The crude incidence
rates were 32.7 per 100,000 for males and 24.9 per 100,000 for females. The corresponding age standardized
rates were 26.4 and 16.7. The sex ratio was 1.6:1. In males, chronic lymphocytic leukaemias were the most
common haematopoietic malignancies, followed by non Hodgkin's lymphomas, acute leukaemias and
multiple myelomas. In females, multiple myelomas and acute leukaemias preceeded non Hodgkin's
lymphomas and chronic lymphocytic leukaemias. For men and women, the risk of haematopoietic
malignancies was higher in urban areas than in rural areas. Compared to population based registries in other
countries, incidence rates are among the highest reported and are particularly high for chronic lymphocytic
leukaemia.
The only data concerning the incidence of haemato-
poietic malignancies prior to 1975 in France came
from death certificates. However, these certificates
are often imprecise or incomplete. Therefore,
French mortality data were not included in the last
volume of Cancer Incidence in Five Continents
(Muir & Waterhouse, 1982). Since 1975, four regis-
tries have been established in France (Schraub,
1983). A population based registry specializing in
haematopoietic malignancies was created in the
department of Cote d'Or in 1980. As population
based registries in France are recent, incidence data
about haematopoietic malignancies in this country
are not yet well known; the purpose of this study is
to report the incidence and the characteristics of
haematopoietic malignancies in the department of
Cote d'Or.
Materials and methods
The study included all patients residing in the
department of Cote d'Or in whom a haematopoietic
malignancy was diagnosed for the first time be-
tween January 1, 1980 and December 31, 1984. The
population of C6te d'Or consisted of 234,900 males
and 243,100 females (Schmitt, 1981). Information
was collected from public and private biological
laboratories, local and private hospital departments,
and general practitioners; death certificates were
also collected. Patients were registered in three
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indexes (by name, by date of birth and by nature of
haemopathy) to eliminate duplication.
This registration took place under excellent con-
ditions; biological information exists for all cases,
clinical information in 98% of the cases, and there
was an average of three notifications per case. The
morbidity/mortality ratio was 1.9.
The registration included all haematopoietic mal-
ignancies and dysmyelopoietic syndromes: acute
leukaemias, lymphoid and myeloid proliferative dis-
orders, Hodgkin's and non Hodgkin's lymphomas.
Acute leukaemias and dysmyelopoietic syndromes
were classified according to the FAB co-operative
group (Bennet et al., 1976). The 8th International
Classification of Diseases was also adopted (World
Health Organization, 1967) to permit comparison
with other countries (Waterhouse et al., 1982) (ICD
codes 200 to 209 inclusive).
Population data used in calculating incidence
rates were based on estimates of the Cote d'Or
population by age and sex, calculated annually by
the Institut National de la Statistique et des Etudes
Economiques (INSEE) by extrapolation from the
1975 census (Schmitt, 1981). For the purpose of
regional comparison, rates have been standardized
by the direct method using the world standard
population (Segi & Kurihara, 1969).
Results
Incidence by site and sex
There were 704 newly diagnosed cases of haemato-
poietic malignancies registered from 1980 to 1984,
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among C6te d'Or residents. The rates standardized
according to the world standard population were
26.4 for males and 16.7 for females. The sex ratio
was 1.6: 1. Incidence rates by sex and nature of
haemopathy are given in Table I. In males, chronic
lymphocytic leukaemias rank first (20% of the
cases) before non Hodgkin's lymphomas (16%),
acute leukaemias (15%), multiple myelomas (12%),
myeloproliferative diseases (14%), Hodgkin's dis-
eases (8%), dysmyelopoietic syndromes (8%) and
other lymphoproliferative diseases (7%). In females,
multiple myelomas rank first (17% of the cases)
with acute leukaemias (17%); they precede non
Hodgkin's lymphomas (16%), chronic lymphocytic
leukaemias (16%), dysmyelopoietic syndromes
(11%), myeloproliferative diseases (10%) and other
lymphoproliferative diseases (5%).
Incidence by age
For the most frequent haemopathies, age and sex
specific incidence rates are given in Figure 1. In
acute leukaemias, incidence rates in males and
females were comparable. In chronic lymphocytic
leukaemias, incidence rates were low before 50
years of age and rose in the older age groups, with
a male predominance. In Hodgkin's lymphoma
there were no cases before 5 years of age, and
incidence was higher between 20 and 55 years old.
In non Hodgkin's lymphoma, the incidence in-
creased in all age groups over 55 years.
The mean ages of the patients at time of diag-
nosis by type of haematopoietic malignancy are
given in Table II. There were no significant dif-
ferences except for chronic lymphocytic leukaemias:
females patients were older than males (P<0.05).
Urban-rural differences
There were no significant variations in incidence for
the different types of haematopoietic malignancy,
but there was a trend towards a higher incidence in
urban than in rural areas for all types except acute
leukaemias in females. When rates were added, the
risk of haematopoietic malignancies was signifi-
cantly higher in urban than in rural areas. In males,
the age standardized rates were respectively
30.9/100,000 and 20.4/100,000 (P<0.01). In
females, they were 18.7/100,000 and 13.9/100,000
(P<0.05).
Classification ofacute leukaemias and
dysmyelopoietic syndromes
They were classified according to FAB classifi-
cation. Out of 112 cases of acute leukaemias, 35
were acute lymphoid leukaemias: there were 21 LI
(59%), 11 L2 (32%), 3 L3 (9%); and 77 acute
myeloid leukaemias: there were 14 MI (18%), 21
M2 (27%), 5 M3 (7%), 14 M4 (18%), 12 M5 (16%),
3 M6 (4%), 8 rare type (10%). Out of 69
dysmyelopoietic syndromes, there were 16 sidero-
Table I Incidence of haematopoietic malignancies by sex
Crude
Number incidence Age
ICD Haemopathy ofcases rates standardized rate
Sex
M F M F M F ratio
200 Non Hodgkin's lymphomas 64 48 5.4 3.9 4.5 2.5 1.8
201 Hodgkin's 32 26 2.7 2.1 2.4 2.1 1.1
204-1 Chronic lymphocytic leukaemias 80 48 6.7 3.8 5.2 1.8 2.9
204-0 Acute lymphoid leukaemia 20 15 1.7 1.2 1.8 1.4 1.3
206-0 Acute myeloid and monocytic leukaemia 39 38 3.3 3.1 2.5 2.3 1.1
203 Multiple myelomas 45 52 3.9 4.4 2.9 2.7 1.1
Waldenstr6m disease 14 3 1.2 0.2 0.8 0.2 4.0
204-2 Other lymphoproliferative diseases 13 7 1.1 0.7 0.9 0.5 1.8
205-1 Chronic myeloid leukaemias 22 4 1.9 0.3 1.7 0.2 8.5
208 Polycythaemia vera 16 10 1.3 0.8 1.0 0.7 1.4
209 Myelofibrosis 6 5 0.5 0.4 0.3 0.3 1.0
205-2 Other myelo-proliferative diseases 12 13 1.0 1.1 0.7 0.8 0.9
Dysmyelopoietic syndromes 34 35 2.9 2.9 1.7 1.4 1.2
Unspecified type 2 1 0.1 0.0
All haematopoietic malignancies 399 305 32.7 24.9 26.4 16.7
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Figure 1 Age specific incidence rate for the most
females (-----).
Table II Meanagesofthepatientsbytypeofhaematopoietic
malignancy
Males Females P
Hodgkin's disease 36.5+16.8 35.6+19.4 NS
Non Hodgkin's
lymphoma 60.7+ 14.3 64.3+ 17.6 NS
Chronic lymphocytic
leukaemia 68.2+ 12.7 73.5+ 13.3 <0.05
Acute lymphoid
leukaemia 24.0+26.4 23.9+24.1 NS
Acute myeloid
leukaemia 63.4+21.4 56.5+26.3 NS
Multiple myeloma 70.8+11.4 70.6+10.7 NS
Chronic myeloid
leukaemia 53.4+ 16.9 49.5+21.7 NS
Polycythaemia vera 66.9+ 10.8 60.3+ 12.5 NS
Myelofibrosis 69.8+ 7.6 71.6+14.9 NS
Dysmyelopoietic
syndrome 71.3+13.7 74.6+11.3 NS
blastic anaemias (23%), 32 refractory anaemias
with excess of blasts (46%), 1 refractory anaemia
without excess of blasts (1%), 14 chronic myelo-
monocytic leukaemias (20%).
Non Hodgkin's lymphoma
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frequent haematopoietic malignancies. Males ( );
Discussion
One of the major problems faced by cancer regis-
tries is the determination of completeness and reli-
ability of the data. Because of the high level of
participation of the whole medical profession in the
department, a large proportion of newly diagnosed
haemopathies was registered. It has been checked
that there were no prevalent cases in the registered
cases.
In this paper, in order to compare our results
with those of other registries (Waterhouse et al.,
1982), it was necessary to use the 8th revision
(World Health Organization, 1967). Available
classification of haematopoietic malignancies in-
volved difficulties: in the 7th revision, it was not even
possible to separate acute and chronic leukaemias.
In the 8th revision, myelodysplastic syndromes were
not included (except chronic monocytic leuka-
emias). In the 9th revision, they were included but
in ICD codes far from those of haematopoietic
malignancies (ICD 284/285-0). In the 10th revision,
it would be unfortunate not to use the FAB
classification concerning acute leukaemias and dys-
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myelopoietic syndromes, seeing that classification is
actually used by most of the haematologists.
One of the most important uses of registered
data is to permit comparison with the data of
cancer registries in other countries (Table III). For
the whole range of haematopoietic malignancies,
high rates are reported in the department of Cote
d'Or as well as in most West European and North
American countries. Incidence rates are in the inter-
mediate range in Norway and South Africa and
they are low in Asia (particularly in Japan). They
are higher in Cote d'Or than in other population-
based French registries. It must be underlined that
an unexpected high incidence rate for chronic
lymphocytic leukaemias was found. There are two
possible explanations for such a special situation.
One is that the incidence of chronic lymphocytic
leukaemia in Cote d'Or does not differ from that in
other places, except that the reporting of the cases
is more complete in Cote d'Or. The other is that
chronic lymphocytic leukaemia is really more frequ-
ent in our department. Case-control studies are
necessary to search for environmental and occupa-
tional factors. The results could explain this high
incidence rate. Formultiple myeloma, the rates are in
the intermediate range, lower than in countries with a
highblackpopulation. Hodgkin's andnon-Hodgkin's
lymphomas are frequent but less than in Geneva
(Switzerland), a very high risk region. For the other
haematopoietic malignancies. Cote d'Or rates are
similar to thosereportedinmostcountries. Asinmost
cancer registries, the male/female ratio of incidence
rates was about 1:1 for acute leukaemias (as for
everywhere in the world), while there was a high male
predominance for chronic leukaemias.
Comparison of urban and rural incidence data
are difficult because the definitions of urban and
rural vary a great deal from one area of the world
to another. The definition of urban and rural used
in France is based on the size of the population;
urban areas include agglomerations of more than
2,000 inhabitants. Although comparisons need to
be treated with caution, they show a similar trend;
there was a tendency towards a slightly higher
urban rate for most of the types of haematopoietic
malignancies (significantly higher for whole haemo-
pathies). In Iowa, an increasing incidence of
chronic lymphocytic leukaemias from urban to
rural areas was noted (Donham et al., 1980). This
fact suggests the possibility of an environmental
exposure. The purpose of population-based regis-
tries is to search for aetiologic factors. They are not
yet known except for therapeutic drugs and
radiation.
There are no comparable population-based statis-
tics concerning classification ofacute leukaemias and
myelodysplastic syndromes according to FAB
classification. In acute lymphoid leukaemias, the LI
was the predominant type, and in acute myeloid
leukaemias the M2 type was more frequent than
Ml, M4 and M5 types. For dysmyelopoietic syn-
dromes, the refractory anaemias with excess of
blasts represent about half of the cases. Compa-
rison with data from Iowa (Dick et al., 1982) shows
similar results except for LI and L2 classes.
However, Cote d'Or data include children, and
those of Dick et al. only adults. These data are
interesting as they concern an overall population.
They provide clinicians with data for reference and
public health authorities with a basis for monitor-
ing cancer patients.
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